Search Results < Yale School of Medicine

31 results

News
Serendipity in action
Richard Edelson, MD: A dermatologist's 'buddy' leads him toward a revolutionary treatment for cancer, infections, and transplants.
20 Mar 2024
News
Novel Immunotherapy Selectively Targets Malignant T Cells
Researchers say the new CAR-T cell therapy significantly reduced the number of cancerous T cells, while leaving healthy cells intact.
24 Jan 2024
News
Blavatnik Fund for Innovation at Yale Awards $2.5 Million to 11 Faculty-Led Projects
The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of biomedical and digital health innovations.
Source: Yale Ventures
24 May 2023
News
Yale Dermatologists Named Connecticut’s ‘Top Doctors’
10 Yale Dermatology primary faculty and 18 community attendings have been named 2023 ‘Top Doctors’ by Connecticut Magazine!
5 May 2023
News
Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians
Each year, Connecticut Magazine recognizes some of the state’s best physicians, who provide exceptional care for patients, with its annual “Top Doctors” issue. This year’s list includes 82 physicians from Smilow Cancer Hospital and Yale Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in the state.
1 May 2023
News
Using Particles That Are Smaller Than the Head of a Pin to Treat Cancer
Thanks in part to research begun more than a decade ago with funding from Women’s Health Research at Yale, Dr. W. Mark Saltzman is working with colleagues on a way to deploy effective cancer-fighting medication safely with the help of nanoparticles.
10 Jul 2022
News
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 87 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2022 Best Doctors guide.
3 May 2022
News
Prurigo Nodularis
Overview Itchy skin is a something we’ve all experienced from time to time, whether from an uncomfortable woolen sweater, seasonal dry skin or, perhaps, as a reaction to certain detergents or personal care products. Sometimes, when an itch lasts long enough—and is severe—it can lead to a condition called prurigo nodularis. A hallmark of prurigo nodularis is the development of firm bumps (called nodules) that intensify the itchiness. People with prurigo nodularis report itching that is so intense it disrupts sleep and prompts so much scratching that the skin begins to bleed. Prurigo nodularis can affect people of any age, though is most common among those in middle age or older. “Prurigo nodularis can be an extremely debilitating condition characterized by a relentless itch,” says Yale Medicine.
22 Apr 2022
News
Sticky Nanoparticles Fight Skin Cancer
Using bioadhesive nanoparticles from the laboratory of Dr. W. Mark Saltzman, Dr. Michael Girardi and his team collaborated with Dr. Saltzman and loaded them with a one-two punch of chemotherapy plus immunotherapy to study its impact in skin cancer. The results may have significant impact for how skin cancer tumors are treated.
30 Mar 2022
News
Dermatology is interdisciplinary to the core
YSM's department of dermatology is a place where specialists come together to practice cutting-edge interdisciplinary research. Experts pool scientific insights and clinical experience in a professional space where all perspectives are welcome.
14 Jan 2022
News
Where dermatology is more than skin deep
In recent times, it has become clear that the skin is an important window into the human body's health. Many systemic diseases can be detected by dermatologists — sarcoidosis, lupus, lymphoma, fungal infections, and melanoma, to name some.
14 Jan 2022
News
Exposing a Cellular Double Agent That Helps Skin Cancer Take Hold
Yale researchers have identified a cellular process that tricks certain immune cells into helping potentially deadly skin cancer to reproduce.
Source: YaleNews
7 Sep 2021
News
Yale dermatologist weighs in on J&J sunscreen recalls, preferred types to protect skin
The FDA realizes that sunscreen use is critical to public health, saying melanoma continues to be on the rise, with most cases caused by excessive sun exposure. Johnson and Johnson recently announced a voluntary recall of five spray sunscreen products under the Neutrogena and Aveeno brands. RELATED: Johnson & Johnson recalling sunscreens due to traces of benzene, cancer-causing chemical The affected products, packaged in aerosol cans, are Aveeno Protect + Refresh aerosol sunscreen, and four Neutrogena sunscreen versions: Beach Defense aerosol sunscreen, CoolDry Sport aerosol sunscreen, Invisible Daily Defense aerosol sunscreen, and UltraSheer aerosol sunscreen. Research by New Haven-based Valisure evaluated sunscreens and after sun products, revealing varying levels of the carcinogen benzene in some. Benzene can be ingested through breathing in, and through the skin making its way into the bloodstream.
Source: News 8 WTNH
15 Jul 2021
News
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 90 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2021 Best Doctors guide. Published in the magazine’s June issue, the 'Best Doctors' list consists of more than 1,500 Connecticut physicians from nearly 40 medical specialties.
2 Jun 2021
News
Video: Yale Researchers Discover Cancerous Skin Tumors May Be Treated With Injection Of Nanoparticles
Nanoparticles, a key component of Moderna and Pfizer’s COVID vaccine, could make cancer treatment as easy as a simple skin injection, Dr. Max Gomez of CBS2 reported Thursday.
Source: CBS New York
4 Feb 2021
News
Yale Researchers Develop Injection to Treat Skin Cancer
Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.
31 Jan 2021
News
Mohs Tied to Better OS in Early Invasive Melanoma
Mohs micrographic surgery was associated with improved survival compared with traditional excision in early invasive melanoma, a retrospective study indicated. Among more than 70,000 stage I patients in a national database, univariate analysis showed no overall survival (OS) difference between the two techniques, but multivariate analysis revealed better OS for those treated with Mohs surgery (HR 0.86, 95% CI 0.76-0.97), Michael Girardi, MD, of Yale School of Medicine in New Haven, Connecticut, and colleagues reported in JAMA Dermatology.
Source: MedPage Today
29 Aug 2019
News
Five Ways to Lower Your Skin Cancer Risk
Summer is here, but enjoying longer and sunnier days outdoors means your skin is vulnerable to sunburn. Experts at Yale Cancer Center (YCC) and Yale School of Medicine (YSM) say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer. Just one sunburn during your youth doubles your chances of developing melanoma, the deadliest form of skin cancer.
23 Jun 2018
News
New technology predicts skin cancer risk
While there’s no magic eight ball for medicine, Yale researchers have managed to predict how likely someone is to develop skin cancer.
1 Feb 2018
News
A new tool against cancer
When two experts in their fields get together and combine their labs, incredible things happen. W.
25 Oct 2017